drugset / Trial / NCT03058536

Progesterone and Cervical Pessary in Twins

NCT03058536

Phase 2/3 Unknown 312 enrolled Mario Henrique Burlacchini de Carvalho
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this randomized control trial is to determine wheter cervical pessary plus vaginal progesterone (400mg) reduce preterm birth less than 34 weeks of gestacion and improve perinatal outcome, among women presenting asyntomatic short cervix, in twin pregnancy.

Timeline

Start
2017-02-21
Primary completion
2019-03
Completion
2019-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 400 mg Other

Indications